-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
NRX Pharmaceuticals, Inc. quarterly/annual Return On Equity history and change rate from Q3 2018 to Q3 2025.
- NRX Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2025 was 139 %, a 14.3% decline year-over-year.
- NRX Pharmaceuticals, Inc. annual Return On Equity for 2024 was 133 %, a 76.8% decline from 2023.
- NRX Pharmaceuticals, Inc. annual Return On Equity for 2023 was 573 %.
- NRX Pharmaceuticals, Inc. annual Return On Equity for 2022 was -196 %, a 102% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)